Sacral neuromodulation for nonobstructive urinary retention: A meta-analysis

被引：36
作者：
Gross C. [1 ,3 ,4 ]
Habli M. [1 ]
Lindsell C. [2 ]
South M. [1 ]
机构：
[1] Departments of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, OH
[2] Departments of Emergency Medicine, University of Cincinnati, Cincinnati, OH
[3] University of Cincinnati, Cincinnati, OH 45267
[4] University of Cincinnati, Cincinnati, OH 45206
来源：
Female Pelvic Medicine and Reconstructive Surgery | 2010年 / 16卷 / 04期
关键词：
Sacral nerve stimulation; Sacral neuromodulation; Urinary retention; Voiding dysfunction;
D O I：
10.1097/SPV.0b013e3181df9b3f
中图分类号：
学科分类号：
摘要：
Objective: The objective of this study is to systematically review the literature regarding the efficacy of sacral neuromodulation (InterStim) for treatment of nonobstructive urinary retention. Methods: Eligible studies were selected through an electronic literature search of PubMed, Cochrane Collaboration, EMBASE, Web of Science and Scopus databases from January 1980 to August 2008. Two investigators independently reviewed all studies to assess methodological quality and inclusion criteria. Eligible studies evaluated sacral neuromodulation using implanted generators with permanent lead placement for treating nonobstructive urinary retention. The primary outcomes assessed were the change in pre- and postoperative postvoid residual and voided volume. Exclusion criteria were neurogenic etiology (ie, spinal cord injury) for urinary retention and non-English studies. The lead authors of all selected studies were contacted to identify ongoing or unpublished research, as was Medtronic, Inc. (Minneapolis, MN). Data were extracted from the selected studies and analyzed using RevMan 5 (Review Manager, Cochrane Collaboration, 2008). The mean difference with a 95% confidence interval was the effect of interest. Results: A total of 14 articles met all inclusion criteria for the systematic review. This included one randomized control trial (RCT) and 13 observational studies. Outcome data was available from a total of 7 studies and used in the final analysis. After implantation, the mean difference in postvoid residual decreased 236 mL (95% CI: 219-253, P < 0.00001) and voided volume increased by 299 mL (95% CI: 280-318, P < 0.00001). The randomized control trial alone (n = 51) showed a mean decrease in postvoid residual volume in the implanted group compared with control of 270 mL (95% CI: 180-360, P < 0.00001) and a mean increase in voided volume of 104 mL (95% CI: 55-152, P < 0.0002). Conclusions: Based on the available literature, sacral neuromodulation is an effective therapy for treatment of nonobstructive urinary retention. Copyright © 2010 by Lippincott Williams & Wilkins.
引用
收藏
页码：249 / 253
页数：4
相关论文
共 18 条
  • [1] Jonas U., Fowler C.J., Chancellor M.B., Et al., Efficacy of sacral nerve stimulation for urinary retention: Results 18 months after implantation, J Urol, 165, pp. 15-19, (2001)
  • [2] Comiter C.V., Sacral nerve stimulation to treat nonobstructive urinary retention in women, Curr Urol Rep, 9, pp. 405-411, (2008)
  • [3] Chartier-Kastler E., Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience, BJU International, 101, 4, pp. 417-423, (2008)
  • [4] Tanagho E.A., Schmidt R.A., Electrical stimulation in the clinical management of the neurogenic bladder, Journal of Urology, 140, 6, pp. 1331-1339, (1988)
  • [5] Aboseif S., Tamaddon K., Chalfin S., Freedman S., Kaptein J., Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction, Urology, 60, 1, pp. 52-56, (2002)
  • [6] Scheepens W.A., Van Koeveringe G.A., De Bie R.A., Weil E.H.J., Van Kerrebroeck Ph.E.V., Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation, BJU International, 90, 9, pp. 840-845, (2002)
  • [7] Datta S.N., Chaliha C., Singh A., Gonzales G., Mishra V.C., Kavia R.B.C., Kitchen N., Fowler C.J., Elneil S., Sacral neurostimulation for urinary retention: 10-Year experience from one UK centre, BJU International, 101, 2, pp. 192-196, (2008)
  • [8] Elabbady A.A., Hassouna M.M., Elhilali M.M., Neural stimulation for chronic voiding dysfunctions, Journal of Urology, 152, 6, pp. 2076-2080, (1994)
  • [9] Everaert K., De Muynck M., Rimbaut S., Weyers S., Urinary retention after hysterectomy for benign disease: Extended diagnostic evaluation and treatment with sacral nerve stimulation, BJU International, 91, 6, pp. 497-501, (2003)
  • [10] Gruenewald V., Jonas U., Neurostimulation for lower urinary tract voiding problems, Curr Urol Rep, 1, pp. 199-203, (2000)
12